MD - MEDNAX, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
2.02B
Enterprise Value 3
3.97B
Trailing P/E
N/A
Forward P/E 1
6.63
PEG Ratio (5 yr expected) 1
1.36
Price/Sales (ttm)
0.55
Price/Book (mrq)
0.71
Enterprise Value/Revenue 3
1.09
Enterprise Value/EBITDA 6
7.57

Trading Information

Stock Price History

Beta (3Y Monthly) 1.19
52-Week Change 3-45.23%
S&P500 52-Week Change 39.71%
52 Week High 342.74
52 Week Low 319.93
50-Day Moving Average 322.45
200-Day Moving Average 324.44

Share Statistics

Avg Vol (3 month) 3868.43k
Avg Vol (10 day) 3871.98k
Shares Outstanding 584.21M
Float 79.47M
% Held by Insiders 13.29%
% Held by Institutions 197.12%
Shares Short (Sep 30, 2019) 46M
Short Ratio (Sep 30, 2019) 45.2
Short % of Float (Sep 30, 2019) 47.87%
Short % of Shares Outstanding (Sep 30, 2019) 47.12%
Shares Short (prior month Aug 30, 2019) 45.85M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Dec 20, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -3.43%
Operating Margin (ttm)11.34%

Management Effectiveness

Return on Assets (ttm)4.50%
Return on Equity (ttm)7.14%

Income Statement

Revenue (ttm)3.65B
Revenue Per Share (ttm)41.96
Quarterly Revenue Growth (yoy)0.40%
Gross Profit (ttm)1.03B
EBITDA 524.7M
Net Income Avi to Common (ttm)211.02M
Diluted EPS (ttm)-1.44
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)107.32M
Total Cash Per Share (mrq)1.29
Total Debt (mrq)2.18B
Total Debt/Equity (mrq)79.82
Current Ratio (mrq)2.23
Book Value Per Share (mrq)32.92

Cash Flow Statement

Operating Cash Flow (ttm)331.16M
Levered Free Cash Flow (ttm)-1.25M